Lung Cancer Clinical Trial

Tempus Sculptor Study: Small Cell Lung Cancer (SCLC) Observational Study

Summary

The study is a non-interventional evaluation of participants with SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA biomarker profiling in addition to their standard of care therapy and disease surveillance.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically confirmed small cell lung cancer diagnosis
Diagnosis made with excisional or core needle biopsy specimen (not aspirate)
ECOG performance status of 0 or 1 at time of enrollment
Planned extensive stage first-line therapy of etoposide plus carboplatin plus PD-L1 inhibitor (atezolizumab or durvalumab)
Extensive stage disease at time of diagnosis
Willing and able to provide informed consent

Exclusion Criteria:

History of radiotherapy to the chest or planned consolidation chest radiotherapy
Prior diagnosis of non-small cell lung cancer
Mixed small cell and non-small cell histology
Suspected metastatic cancer from other sites (i.e., those without a known or suspected lung primary diagnosis)
Not willing to have additional blood samples collected
Ineligible for biopsy of lung primary or non-liver/bile metastatic site

Study is for people with:

Lung Cancer

Estimated Enrollment:

50

Study ID:

NCT05257551

Recruitment Status:

Recruiting

Sponsor:

Tempus Labs

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

Illinois Cancer Care
Peoria Illinois, 61615, United States More Info
Trupti Hattiangadi
Contact
309-243-3000
Mohammad (Fahad) Asad, MD
Principal Investigator
Englewood Health Medical Center
Englewood New Jersey, 07631, United States More Info
Hauwa Adeniji
Contact
201-608-2846
Meghan Kaumaya, MD
Principal Investigator
TriHealth Cancer Institute
Cincinnati Ohio, 45220, United States More Info
Nicholas Morgan
Contact
513-479-3402
James Maher, MD
Principal Investigator
OhioHealth Research Institute
Columbus Ohio, 43214, United States More Info
Hazel Antao
Contact
614-788-3880
Arvinder Bhinder, MD
Principal Investigator
Cancer Care Association of York
York Pennsylvania, 17403, United States More Info
Jennifer Stough
Contact
Contact
717-741-9229
Chanh Huynh, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

50

Study ID:

NCT05257551

Recruitment Status:

Recruiting

Sponsor:


Tempus Labs

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.